Understanding immune cells that target brain tumors
Characterization of brain metastasis-specific CD8+ T cells
This study is looking at special immune cells called CD8+ T cells that help fight brain tumors, to understand why they sometimes become tired and less effective, with the hope of finding better ways to boost their power against these tough cancers.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10886075 on NIH RePORTER |
What this research studies
This research investigates the characteristics of CD8+ T cells, which are crucial immune cells that can kill cancer cells, specifically in the context of brain metastases. The study aims to understand how these T cells become exhausted and how this affects their ability to fight tumors in the brain. By analyzing different populations of these T cells, the research seeks to identify new strategies to enhance their effectiveness against brain tumors, which are often resistant to current treatments. Patients may benefit from insights that could lead to improved immunotherapy options for brain metastases.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with brain metastases from various cancers who are seeking new treatment options.
Not a fit: Patients with primary brain tumors or those without brain metastases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with brain metastases, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in using immune checkpoint blockade therapies for treating various cancers, indicating potential for success in this novel approach for brain metastases.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Sudmeier, Lisa — Emory University
- Study coordinator: Sudmeier, Lisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.